NANOVERSE
LIVE

Serial Number

99664913

Owner

Caris MPI, Inc.

Attorney

Anne Fleeson

Filing Date

Feb 23, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NANOVERSE Trademark

Serial Number: 99664913

NANOVERSE is a trademark filed by Caris MPI, Inc. on February 23, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Caris MPI, Inc. (115 trademarks)

6655 N. MacArthur Blvd.
Irving, TX 75039

Entity Type: 03

Trademark Details

Filing Date

February 23, 2026

Registration Date

Not Registered

Goods & Services

Medical analysis services for the diagnosis and treatment of persons in the field of molecular biology, namely, analyzing molecular data, identifying patient populations, detecting and characterizing disease, predicting treatment responses, and identifying targets for drug development

Medical and scientific research services in the field of molecular biology, namely, analyzing molecular data, identifying patient populations, detecting and characterizing disease, predicting treatment responses, and identifying targets for drug development; Scientific research laboratory analysis services in the field of molecular biology, namely, analyzing molecular data, identifying patient populations, detecting and characterizing disease, predicting treatment responses, and identifying targets for drug development; Providing online non-downloadable software featuring artificial intelligence for analyzing molecular data, identifying patient populations, detecting and characterizing disease, predicting treatment responses, and identifying targets for drug development

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 14, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 13, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 24, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 24, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 20, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 18, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 25, 2026 MAFR
NEW APPLICATION ENTERED
Feb 23, 2026 NWAP